Welcome to LookChem.com Sign In|Join Free
  • or
4-((N-benzyl-4-chlorophenylsulfonamido)methyl)benzoic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

721416-48-4

Post Buying Request

721416-48-4 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

721416-48-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 721416-48-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,2,1,4,1 and 6 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 721416-48:
(8*7)+(7*2)+(6*1)+(5*4)+(4*1)+(3*6)+(2*4)+(1*8)=134
134 % 10 = 4
So 721416-48-4 is a valid CAS Registry Number.

721416-48-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 4-{[benzyl(4-chlorobenzenesulfonyl)amino]methyl}benzoic acid

1.2 Other means of identification

Product number -
Other names 4-((N-benzyl-4-chlorophenylsulfonamido)methyl)benzoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:721416-48-4 SDS

721416-48-4Relevant academic research and scientific papers

Discovery of a novel series of CXCR3 antagonists

Crosignani, Stefano,Missotten, Marc,Cleva, Christophe,Dondi, Ruggero,Ratinaud, Yann,Humbert, Yves,Mandal, Ashis Baran,Bombrun, Agns,Power, Christine,Chollet, Andre,Proudfoot, Amanda

supporting information; experimental part, p. 3614 - 3617 (2010/09/17)

The discovery of a novel series of CXCR3 antagonists is described. Starting from an HTS positive, iterative optimization gave potent compounds (IC 50 15 nM in a chemotaxis assay). The strategy employed to improve the metabolic stability of these derivatives is described.

SULFONAMIDES

-

, (2009/11/29)

The invention relates to compounds of formula (I) wherein R1, R2, R4, Ra, Rb, Rc, Re, A*, W1, W2 and W3 are as defined in claim 1, for the treatment of CXCR3 related diseases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 721416-48-4